FNIP2

folliculin interacting protein 2, the group of DENN domain containing

Basic information

Region (hg38): 4:158769026-158908050

Links

ENSG00000052795NCBI:57600OMIM:612768HGNC:29280Uniprot:Q9P278AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FNIP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FNIP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
51
clinvar
8
clinvar
1
clinvar
60
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 51 10 2

Variants in FNIP2

This is a list of pathogenic ClinVar variants found in the FNIP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-158769237-C-G not specified Uncertain significance (Dec 10, 2024)3516470
4-158769276-G-A not specified Uncertain significance (Oct 04, 2024)3516472
4-158769277-C-T not specified Uncertain significance (Jun 12, 2023)2525317
4-158825920-T-C not specified Uncertain significance (Jul 14, 2021)2333625
4-158825942-A-G not specified Uncertain significance (Jul 27, 2024)3516477
4-158825988-A-T not specified Uncertain significance (Sep 05, 2024)3516475
4-158829131-G-A not specified Uncertain significance (Jun 03, 2024)3279446
4-158831874-C-T not specified Uncertain significance (Jan 19, 2024)3096152
4-158833607-T-C not specified Uncertain significance (Apr 25, 2022)2286061
4-158851378-C-G not specified Uncertain significance (Jun 07, 2023)2515241
4-158859090-A-T not specified Uncertain significance (Oct 06, 2021)3096153
4-158859136-A-G not specified Uncertain significance (Apr 06, 2024)3279439
4-158859140-G-A not specified Uncertain significance (Jun 01, 2023)2554870
4-158859193-T-G not specified Uncertain significance (Sep 14, 2022)2312043
4-158859194-T-A not specified Uncertain significance (Sep 14, 2022)2312044
4-158859236-G-A not specified Uncertain significance (Jun 09, 2022)2294275
4-158859585-T-A not specified Uncertain significance (Jul 25, 2024)3516476
4-158859639-G-A not specified Uncertain significance (Mar 01, 2024)2282167
4-158861361-T-C not specified Uncertain significance (Jul 20, 2022)2302692
4-158861448-A-G not specified Uncertain significance (Oct 03, 2022)2221356
4-158861468-A-G not specified Uncertain significance (Feb 14, 2024)2231944
4-158861630-C-T not specified Uncertain significance (May 17, 2023)2517322
4-158861662-A-G not specified Uncertain significance (Jan 20, 2023)2476912
4-158861711-G-C not specified Uncertain significance (Sep 27, 2024)3516480
4-158861713-A-G not specified Uncertain significance (Jan 03, 2024)3096135

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FNIP2protein_codingprotein_codingENST00000264433 17138912
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.006.53e-7124633071246400.0000281
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.285176060.8540.00003257303
Missense in Polyphen106180.390.587612202
Synonymous0.6532132250.9450.00001282178
Loss of Function6.18248.50.04130.00000255581

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.00005570.0000556
Finnish0.000.00
European (Non-Finnish)0.00002660.0000265
Middle Eastern0.00005570.0000556
South Asian0.00006540.0000654
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a co-chaperone of HSP90AA1. Inhibits the ATPase activity of HSP90AA1 leading to reduction in its chaperone activity. Facilitates the binding of client protein FLCN to HSP90AA1 (PubMed:27353360). May play a role in the signal transduction pathway of apoptosis induced by O6-methylguanine- mispaired lesions (By similarity). May be involved in energy and/or nutrient sensing through the AMPK and mTOR signaling pathways (PubMed:18403135). May regulate phosphorylation of RPS6KB1 (PubMed:18663353). {ECO:0000250|UniProtKB:Q80TD3, ECO:0000269|PubMed:18403135, ECO:0000269|PubMed:18663353, ECO:0000269|PubMed:27353360}.;
Pathway
mTOR signaling pathway - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.0828

Intolerance Scores

loftool
0.243
rvis_EVS
-0.1
rvis_percentile_EVS
45.65

Haploinsufficiency Scores

pHI
0.115
hipred
Y
hipred_score
0.547
ghis
0.451

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.175

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fnip2
Phenotype
neoplasm; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;regulation of protein phosphorylation;protein phosphorylation;mitochondrion organization;intrinsic apoptotic signaling pathway in response to DNA damage;positive regulation of protein complex assembly;positive regulation of peptidyl-serine phosphorylation;TORC1 signaling;negative regulation of catalytic activity
Cellular component
cytoplasm
Molecular function
protein binding;ATPase inhibitor activity;chaperone binding